{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:04:42Z","timestamp":1790409882743,"version":"4.1.0"},"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2011,1,31]],"date-time":"2011-01-31T00:00:00Z","timestamp":1296432000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0016706","type":"journal-article","created":{"date-parts":[[2011,1,31]],"date-time":"2011-01-31T21:57:19Z","timestamp":1296511039000},"page":"e16706","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":60,"title":["Resistance to MPTP-Neurotoxicity in \u03b1-Synuclein Knockout Mice Is Complemented by Human \u03b1-Synuclein and Associated with Increased \u03b2-Synuclein and Akt Activation"],"prefix":"10.1371","volume":"6","author":[{"given":"Bobby","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen S.","family":"Mandir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neva","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaida A.","family":"Andrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Stirling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valina L.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,1,31]]},"reference":[{"key":"ref1","first-page":"1044","article-title":"Parkinson's disease. First of two parts.","volume":"339","author":"AE Lang","year":"1998","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1093\/hmg\/ddm159","article-title":"Parkinson's disease.","volume":"Spec No. 2","author":"B Thomas","year":"2007","journal-title":"Hum Mol Genet 16"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.","volume":"276","author":"MH Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.","volume":"18","author":"R Kruger","year":"1998","journal-title":"Nat Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease.","volume":"302","author":"AB Singleton","year":"2003","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.","volume":"55","author":"JJ Zarranz","year":"2004","journal-title":"Ann Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies.","volume":"388","author":"MG Spillantini","year":"1997","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/35006074","article-title":"A Drosophila model of Parkinson's disease.","volume":"404","author":"MB Feany","year":"2000","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.","volume":"287","author":"E Masliah","year":"2000","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.","volume":"34","author":"BI Giasson","year":"2002","journal-title":"Neuron"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1073\/pnas.132197599","article-title":"Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 \u2013> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.","volume":"99","author":"MK Lee","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI200215777","article-title":"Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies.","volume":"110","author":"M Neumann","year":"2002","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1326-4-34","article-title":"Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons.","volume":"4","author":"JP Daher","year":"2009","journal-title":"Mol Neurodegener"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.","volume":"22","author":"D Kirik","year":"2002","journal-title":"J Neurosci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1073\/pnas.0536383100","article-title":"Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease.","volume":"100","author":"D Kirik","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","article-title":"Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.","volume":"91","author":"M Yamada","year":"2004","journal-title":"J Neurochem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1523\/JNEUROSCI.4965-05.2006","article-title":"Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.","volume":"26","author":"GK Tofaris","year":"2006","journal-title":"J Neurosci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1471-4159.2006.04310.x","article-title":"Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra.","volume":"100","author":"JL St Martin","year":"2007","journal-title":"J Neurochem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1440-1789.2001.00402.x","article-title":"Neurotoxicity of MPTP.","volume":"21","author":"T Fukuda","year":"2001","journal-title":"Neuropathology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1002\/mds.10140","article-title":"Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back.","volume":"17","author":"H Bergman","year":"2002","journal-title":"Mov Disord"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","article-title":"Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.","volume":"102","author":"F Fornai","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00001756-200001170-00041","article-title":"MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons.","volume":"11","author":"NW Kowall","year":"2000","journal-title":"Neuroreport"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0006-8993(02)03514-X","article-title":"Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease.","volume":"956","author":"GE Meredith","year":"2002","journal-title":"Brain Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1046\/j.1471-4159.2001.00366.x","article-title":"Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice.","volume":"77","author":"S Rathke-Hartlieb","year":"2001","journal-title":"J Neurochem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/neu.10094","article-title":"Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.","volume":"53","author":"Z Dong","year":"2002","journal-title":"J Neurobiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0014-4886(03)00342-X","article-title":"Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.","volume":"186","author":"DD Song","year":"2004","journal-title":"Exp Neurol"},{"key":"ref27","article-title":"Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice.","author":"M Nieto","year":"2005","journal-title":"Neurobiol Aging"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1073\/pnas.172514599","article-title":"Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.","volume":"99","author":"W Dauer","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0306-4522(03)00036-8","article-title":"Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.","volume":"118","author":"OM Schluter","year":"2003","journal-title":"Neuroscience"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.neuro.2004.05.002","article-title":"Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.","volume":"25","author":"RE Drolet","year":"2004","journal-title":"Neurotoxicology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1471-4159.2004.02378.x","article-title":"Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha\/gamma-synuclein null mutant mice.","volume":"89","author":"DC Robertson","year":"2004","journal-title":"J Neurochem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1471-4159.1993.tb03271.x","article-title":"Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2\u2032-aminophenyl)-1,2,3,6-tetrahydropyridine (2\u2032-NH2-MPTP): a comparative study with 2\u2032-CH3-MPTP and MPTP.","volume":"60","author":"AM Andrews","year":"1993","journal-title":"J Neurochem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0022-3565(25)39594-7","article-title":"2\u2032-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.","volume":"267","author":"AM Andrews","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining.","volume":"77","author":"NA Tatton","year":"1997","journal-title":"Neuroscience"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","article-title":"Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.","volume":"4","author":"V Jackson-Lewis","year":"1995","journal-title":"Neurodegeneration"},{"key":"ref36","first-page":"35","article-title":"Mechanisms of MPTP toxicity.","volume":"13","author":"S Przedborski","year":"1998","journal-title":"Mov Disord"},{"key":"ref37","article-title":"Cell Death in Parkinson's Disease;","author":"CJ Faherty","year":"2004"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neulet.2006.03.017","article-title":"Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL\/6 mice.","volume":"401","author":"S Ohashi","year":"2006","journal-title":"Neurosci Lett"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0006-8993(02)04085-4","article-title":"Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL\/6 mice.","volume":"964","author":"S Sugama","year":"2003","journal-title":"Brain Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2202-2-11","article-title":"Deletion of the alpha-synuclein locus in a subpopulation of C57BL\/6J inbred mice.","volume":"2","author":"CG Specht","year":"2001","journal-title":"BMC Neurosci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system.","volume":"25","author":"A Abeliovich","year":"2000","journal-title":"Neuron"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models.","volume":"39","author":"W Dauer","year":"2003","journal-title":"Neuron"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(93)90384-T","article-title":"Fluoxetine and desipramine selectively attenuate 2\u2032-NH2-MPTP-induced depletions in serotonin and norepinephrine.","volume":"250","author":"AM Andrews","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0026-895X(25)09609-9","article-title":"Transgenic mice with high levels of superoxide dismutase activity are protected from the neurotoxic effects of 2\u2032-NH2-MPTP on serotonergic and noradrenergic nerve terminals.","volume":"50","author":"AM Andrews","year":"1996","journal-title":"Mol Pharmacol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"37330","DOI":"10.1074\/jbc.M306083200","article-title":"Beta-synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine-induced caspase 3 activation: cross-talk with alpha-synuclein and implication for Parkinson's disease.","volume":"278","author":"CA da Costa","year":"2003","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1093\/hmg\/ddl242","article-title":"Beta-synuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression.","volume":"15","author":"Y Fan","year":"2006","journal-title":"Hum Mol Genet"},{"key":"ref47","first-page":"213","article-title":"beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor.","volume":"32","author":"M Hashimoto","year":"2001","journal-title":"Neuron"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.gt.3302349","article-title":"An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model.","volume":"11","author":"M Hashimoto","year":"2004","journal-title":"Gene Ther"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"23622","DOI":"10.1074\/jbc.M313784200","article-title":"Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease.","volume":"279","author":"M Hashimoto","year":"2004","journal-title":"J Biol Chem"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.0953-816X.2004.03139.x","article-title":"Risk factors for dopaminergic neuron loss in human alpha-synuclein transgenic mice.","volume":"19","author":"MJ Thiruchelvam","year":"2004","journal-title":"Eur J Neurosci"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1471-4159.2000.740721.x","article-title":"Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.","volume":"74","author":"M Vila","year":"2000","journal-title":"J Neurochem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1471-4159.2001.00174.x","article-title":"Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.","volume":"76","author":"S Przedborski","year":"2001","journal-title":"J Neurochem"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"15240","DOI":"10.1074\/jbc.M312497200","article-title":"Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide.","volume":"279","author":"SV Kalivendi","year":"2004","journal-title":"J Biol Chem"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0306-4522(00)00077-4","article-title":"Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation.","volume":"97","author":"S Kanda","year":"2000","journal-title":"Neuroscience"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00001756-200207190-00013","article-title":"Expression of mutant alpha-synucleins enhances dopamine transporter-mediated MPP+ toxicity in vitro.","volume":"13","author":"V Lehmensiek","year":"2002","journal-title":"Neuroreport"},{"key":"ref56","article-title":"Mice lacking alpha-synuclein are resistant to mitochondrial toxins.","author":"P Klivenyi","year":"2005","journal-title":"Neurobiol Dis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"18757","DOI":"10.1073\/pnas.0606401103","article-title":"Oncoprotein Akt\/PKB induces trophic effects in murine models of Parkinson's disease.","volume":"103","author":"V Ries","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1296","article-title":"Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia.","volume":"36","author":"ES Emamian","year":"2004","journal-title":"Nat Genet"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","article-title":"An Akt\/beta-arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior.","volume":"122","author":"JM Beaulieu","year":"2005","journal-title":"Cell"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0006-8993(01)02772-X","article-title":"Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease.","volume":"914","author":"E Rockenstein","year":"2001","journal-title":"Brain Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ncb1441","article-title":"A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling.","volume":"8","author":"L Fallon","year":"2006","journal-title":"Nat Cell Biol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"13670","DOI":"10.1073\/pnas.0504610102","article-title":"Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase\/Akt signaling.","volume":"102","author":"Y Yang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1073\/pnas.0914876107","article-title":"DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway.","volume":"107","author":"H Aleyasin","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1.","volume":"304","author":"EM Valente","year":"2004","journal-title":"Science"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbrc.2010.07.033","article-title":"Oxidative stress alters the regulatory control of p66Shc and Akt in PINK1 deficient cells.","volume":"399","author":"MC Maj","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","article-title":"The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety.","volume":"76","author":"S Przedborski","year":"2001","journal-title":"J Neurochem"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nbd.2006.12.021","article-title":"MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity.","volume":"26","author":"B Thomas","year":"2007","journal-title":"Neurobiol Dis"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1523\/JNEUROSCI.20-02-00771.2000","article-title":"BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain.","volume":"20","author":"LA Mamounas","year":"2000","journal-title":"J Neurosci"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.neuroscience.2009.04.031","article-title":"A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL\/6J mouse.","volume":"161","author":"ZC Baquet","year":"2009","journal-title":"Neuroscience"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0197-4580(93)90112-O","article-title":"New stereological methods for counting neurons.","volume":"14","author":"MJ West","year":"1993","journal-title":"Neurobiol Aging"},{"key":"ref71","article-title":"The mouse brain in stereotaxic coordinates.","author":"KBJ Franklin","year":"1997"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ar.1092310411","article-title":"Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator.","volume":"231","author":"MJ West","year":"1991","journal-title":"Anat Rec"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1523\/JNEUROSCI.1370-04.2004","article-title":"Stabilization of alpha-synuclein protein with aging and familial parkinson's disease-linked A53T mutation.","volume":"24","author":"W Li","year":"2004","journal-title":"J Neurosci"}],"updated-by":[{"DOI":"10.1371\/annotation\/f743434e-a6bf-4c6c-a836-ae5af66035a4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2012,3,19]],"date-time":"2012-03-19T00:00:00Z","timestamp":1332115200000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0016706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T08:08:58Z","timestamp":1740902938000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0016706"}},"subtitle":[],"editor":[{"given":"Mel","family":"Feany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,1,31]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,1,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0016706","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/f743434e-a6bf-4c6c-a836-ae5af66035a4","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,31]]}}}